Adar1 Capital Management, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 6,000 shares of FDMT stock, worth $37,860. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,000
Previous 2,000
200.0%
Holding current value
$37,860
Previous $42 Million
54.5%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$46.6 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$32.2 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$30.9 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$27.8 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$25.8 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $204M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...